195 related articles for article (PubMed ID: 18062896)
1. Intracardiac and intrarenal renin-angiotensin systems: mechanisms of cardiovascular and renal effects.
Raizada V; Skipper B; Luo W; Griffith J
J Investig Med; 2007 Nov; 55(7):341-59. PubMed ID: 18062896
[TBL] [Abstract][Full Text] [Related]
2. Tissue renin-angiotensin systems. Their role in cardiovascular disease.
Lee MA; Böhm M; Paul M; Ganten D
Circulation; 1993 May; 87(5 Suppl):IV7-13. PubMed ID: 8485836
[TBL] [Abstract][Full Text] [Related]
3. The renin-angiotensin system in thyroid disorders and its role in cardiovascular and renal manifestations.
Vargas F; Rodríguez-Gómez I; Vargas-Tendero P; Jimenez E; Montiel M
J Endocrinol; 2012 Apr; 213(1):25-36. PubMed ID: 22043064
[TBL] [Abstract][Full Text] [Related]
4. RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney.
Sachetelli S; Liu Q; Zhang SL; Liu F; Hsieh TJ; Brezniceanu ML; Guo DF; Filep JG; Ingelfinger JR; Sigmund CD; Hamet P; Chan JS
Kidney Int; 2006 Mar; 69(6):1016-23. PubMed ID: 16528251
[TBL] [Abstract][Full Text] [Related]
5. [Renaissance of the renin-angiotensin system in the pathogenesis and therapy of arterial hypertension].
Horký K
Cas Lek Cesk; 1989 Sep; 128(37):1161-5. PubMed ID: 2805032
[TBL] [Abstract][Full Text] [Related]
6. The renin-angiotensin-aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states.
Brewster UC; Setaro JF; Perazella MA
Am J Med Sci; 2003 Jul; 326(1):15-24. PubMed ID: 12861121
[TBL] [Abstract][Full Text] [Related]
7. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
Chung S; Park CW; Shin SJ; Lim JH; Chung HW; Youn DY; Kim HW; Kim BS; Lee JH; Kim GH; Chang YS
Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
[TBL] [Abstract][Full Text] [Related]
8. Expression of genes of the cardiac and renal renin-angiotensin systems in preterm piglets: is this system a suitable target for therapeutic intervention?
Kim E; Eiby Y; Lumbers E; Boyce A; Gibson K; Lingwood B
Ther Adv Cardiovasc Dis; 2015 Oct; 9(5):285-96. PubMed ID: 25817302
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease.
Tikellis C; Bernardi S; Burns WC
Curr Opin Nephrol Hypertens; 2011 Jan; 20(1):62-8. PubMed ID: 21099686
[TBL] [Abstract][Full Text] [Related]
10. The renin-angiotensin system as a risk factor and therapeutic target for cardiovascular and renal disease.
Volpe M; Savoia C; De Paolis P; Ostrowska B; Tarasi D; Rubattu S
J Am Soc Nephrol; 2002 Nov; 13 Suppl 3():S173-8. PubMed ID: 12466309
[TBL] [Abstract][Full Text] [Related]
11. How hematopoietic stem cells know and act in cardiac microenvironment for stem cell plasticity? Impact of local renin-angiotensin systems.
Oztürk MA; Güven GS; Haznedaroglu IC
Med Hypotheses; 2004; 63(5):866-74. PubMed ID: 15488662
[TBL] [Abstract][Full Text] [Related]
12. A new cardiac MASTer switch for the renin-angiotensin system.
Le TH; Coffman TM
J Clin Invest; 2006 Apr; 116(4):866-9. PubMed ID: 16585956
[TBL] [Abstract][Full Text] [Related]
13. Effect of high salt intake on local renin-angiotensin system and ventricular dysfunction following myocardial infarction in rats.
de Resende MM; Mill JG
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):274-9. PubMed ID: 17324137
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II as a cardiovascular risk factor.
Gavras I; Gavras H
J Hum Hypertens; 2002 May; 16 Suppl 2():S2-6. PubMed ID: 11967726
[TBL] [Abstract][Full Text] [Related]
15. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease.
Loghman-Adham M; Soto CE; Inagami T; Cassis L
Am J Physiol Renal Physiol; 2004 Oct; 287(4):F775-88. PubMed ID: 15187005
[TBL] [Abstract][Full Text] [Related]
16. The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets.
Steckelings UM; Rompe F; Kaschina E; Unger T
Fundam Clin Pharmacol; 2009 Dec; 23(6):693-703. PubMed ID: 19817870
[TBL] [Abstract][Full Text] [Related]
17. A new look at the renin-angiotensin system--focusing on the vascular system.
Nguyen Dinh Cat A; Touyz RM
Peptides; 2011 Oct; 32(10):2141-50. PubMed ID: 21945916
[TBL] [Abstract][Full Text] [Related]
18. The renin-angiotensin-aldosterone system: approaches to cardiac and renal therapy.
Otte M; Spier A
Compend Contin Educ Vet; 2009 Jan; 31(1):E1-7; quiz E7. PubMed ID: 19241351
[TBL] [Abstract][Full Text] [Related]
19. Recent changes in the landscape of combination RAS blockade.
Epstein BJ; Smith SM; Choksi R
Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
[TBL] [Abstract][Full Text] [Related]
20. The importance of the renin-angiotensin system in cardiovascular disease.
Nicholls MG; Richards AM; Agarwal M
J Hum Hypertens; 1998 May; 12(5):295-9. PubMed ID: 9655650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
